Savara (SVRA) Shares Outstanding (Diluted Average) (2021 - 2026)

Savara (SVRA) reported Shares Outstanding (Diluted Average) of $253.3 million for Q1 2026, up 17.18% year-over-year from $216.1 million in Q1 2025, and up 13.89% on a QoQ basis from $222.4 million in Q4 2025.

Savara (SVRA) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $253.3 million in Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 17.18% year-over-year to $253.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.3 million (up 17.18% YoY) and the FY2025 annual result came in at $222.4 million, up 12.21% from the prior year.
  • Shares Outstanding (Diluted Average) climbed to $253.3 million in Q1 2026 per SVRA's latest filing, from $222.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $253.3 million in Q1 2026 and bottomed at $152.8 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $182.6 million (2024), against an average of $184.5 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) gained 0.01%; it then gained 19.97% in 2024.
  • Tracing SVRA's Shares Outstanding (Diluted Average) over 5 years: stood at $152.8 million in 2022, then gained by 8.14% to $165.2 million in 2023, then grew by 19.97% to $198.2 million in 2024, then grew by 12.21% to $222.4 million in 2025, then gained by 13.89% to $253.3 million in 2026.
  • Per Business Quant, the three latest SVRA Shares Outstanding (Diluted Average) figures stand at $253.3 million (Q1 2026), $222.4 million (Q4 2025), and $216.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 810.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 118.76 Bn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 256.30 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 138.23 Mn
10 Savara 1.30 Bn 1.30 Bn - 253.28 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 253.28 Mn
Dec 31, 2025 222.39 Mn
Sep 30, 2025 216.46 Mn
Jun 30, 2025 216.29 Mn
Mar 31, 2025 216.15 Mn
Dec 31, 2024 198.19 Mn
Sep 30, 2024 192.40 Mn
Jun 30, 2024 182.57 Mn
Mar 31, 2024 182.55 Mn
Dec 31, 2023 165.20 Mn
Sep 30, 2023 174.70 Mn
Jun 30, 2023 152.80 Mn
Mar 31, 2023 152.78 Mn
Dec 31, 2022 152.77 Mn
Sep 30, 2022 152.77 Mn
Jun 30, 2022 152.77 Mn
Mar 31, 2022 152.77 Mn
Dec 31, 2021 133.92 Mn
Sep 30, 2021 127.62 Mn
Jun 30, 2021 152.46 Mn